Distreptaza

Rectal suppositories indicated for:

1) Supportive treatment of pelvic inflammatory disease (PID) –  inflammatory diseases of the ovaries, fallopian tubes and endometrium,
2) Adhesions after abdominal surgical procedures,
3) Acute haemorrhoidal disease and chronic haemorrhoidal disease,
4) As an supportive treatment in perirectal abscesses and fistulas with extensive inflammatory infiltration.

Each suppository (2 g) contains 15000 IU of streptokinase (Streptokinasum) and 1250 IU of streptodornase (Streptodornasum).